避险基金Archon和ExodusPoint大幅增加了它们对医疗供应商OraSure技术的股份。 Hedge funds Archon and ExodusPoint dramatically increased their stakes in medical supplier OraSure Technologies.

Archon Capital Management和ExodusPoint Capital Management在Orasin Technologies(医疗工具供应商)的股份大为增加。 Archon Capital Management and ExodusPoint Capital Management have significantly increased their stakes in OraSure Technologies, a medical instruments supplier. Archon现在拥有827 777股股票,增加了145.1%,而ExodusPoint的股票增加了1,007.1%,价值610 000美元。 Archon now owns 827,777 shares, an increase of 145.1%, while ExodusPoint's shares rose by 1,007.1% to $610,000 worth of stock. OraSure提供诊断检测、标本收集装置和微生物服务,市场上限为2.1916亿美元。 OraSure provides diagnostic tests, specimen collection devices, and microbiome services with a market cap of $219.16 million.